Trials / Unknown
UnknownNCT05362682
Effectiveness Evaluation of the Sinopharm Vaccine in the Dondo District in Mozambique
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (estimated)
- Sponsor
- International Vaccine Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Three complementary activities will be implemented:1) Baseline and repeat census of the catchment population; described in a separate protocol (IVI-ECOVA-03-WS1); 2) Enhanced surveillance for COVID-19 disease, and 3) AEFI-enhanced surveillance. The mass vaccination campaign will be conducted by the Government and is not part of this protocol.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Sinopharm Vaccine | Sinopharm Vaccine will be administered by the Govt as part of COVID-19vaccination campaign |
Timeline
- Start date
- 2022-02-24
- Primary completion
- 2024-02-28
- Completion
- 2024-08-30
- First posted
- 2022-05-05
- Last updated
- 2023-04-19
Locations
1 site across 1 country: Mozambique
Source: ClinicalTrials.gov record NCT05362682. Inclusion in this directory is not an endorsement.